Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Fifteen-year trends in metastatic breast cancer survival in Greece.

Dafni U, Grimani I, Xyrafas A, Eleftheraki AG, Fountzilas G.

Breast Cancer Res Treat. 2010 Feb;119(3):621-31. doi: 10.1007/s10549-009-0630-8.

PMID:
19915976
2.

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.

Pentheroudakis G, Fountzilas G, Bafaloukos D, Koutsoukou V, Pectasides D, Skarlos D, Samantas E, Kalofonos HP, Gogas H, Pavlidis N.

Breast Cancer Res Treat. 2006 Jun;97(3):237-44. Epub 2005 Dec 2.

PMID:
16322882
3.

A systematic overview of chemotherapy effects in breast cancer.

Bergh J, Jönsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):253-81. Review.

PMID:
11441936
7.

Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.

Nisticò C, Cuppone F, Bria E, Fornier M, Giannarelli D, Mottolese M, Novelli F, Natoli G, Cognetti F, Terzoli E.

Anticancer Drugs. 2006 Nov;17(10):1193-200.

PMID:
17075319
8.

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer.

Chia SK, Speers CH, D'yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'reilly SE, Olivotto IA.

Cancer. 2007 Sep 1;110(5):973-9.

9.

Long-term follow-up of patients with metastatic breast cancer: results of a retrospective, single-center analysis from 2000 to 2005.

Geiger S, Cnossen JA, Horster S, DiGioia D, Heinemann V, Stemmler HJ.

Anticancer Drugs. 2011 Oct;22(9):933-9. doi: 10.1097/CAD.0b013e32834860af.

PMID:
21666437
10.

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.

Gennari A, Sormani MP, Pronzato P, Puntoni M, Colozza M, Pfeffer U, Bruzzi P.

J Natl Cancer Inst. 2008 Jan 2;100(1):14-20. Epub 2007 Dec 25.

PMID:
18159072
11.

Adjuvant therapy for breast cancer.

Hennessy BT, Pusztai L.

Minerva Ginecol. 2005 Jun;57(3):305-26. Review.

PMID:
16166938
13.

Carboplatin in combination therapy for metastatic breast cancer.

Perez EA.

Oncologist. 2004;9(5):518-27. Review.

14.

[Current trends in pharmacotherapy of breast cancer].

Boér K.

Orv Hetil. 2002 Apr 7;143(14):725-30. Review. Hungarian.

PMID:
11975393
15.

Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.

Sonneveld DJ, Hoekstra HJ, van der Graaf WT, Sluiter WJ, Mulder NH, Willemse PH, Koops HS, Sleijfer DT.

Cancer. 2001 Apr 1;91(7):1304-15.

PMID:
11283931
16.

Adjuvant therapy for breast cancer.

[No authors listed]

NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. Review.

PMID:
11512506
17.

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.

Willner J, Kiricuta IC, Kölbl O.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):853-63.

PMID:
9128962
18.

Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials.

Gueth U, Huang DJ, Schoetzau A, Holzgreve W, Wight E.

Oncology. 2009;76(4):247-53. doi: 10.1159/000205387. Epub 2009 Feb 25.

PMID:
19246949
19.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
20.

Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.

Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM; GEICAM 9906 Study Investigators.

J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27.

Supplemental Content

Support Center